---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047421"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:57:59.608574+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical faces Nasdaq delisting over late Q3 2024 10-Q; hearing Dec 16

## Summary
- Received Nasdaq notice on Nov 18, 2024 for failure to file Form 10-Q for period ended Sep 30, 2024.
- This is an additional basis for delisting; prior delinquencies include 2023 10-K and Q1/Q2 2024 10-Qs.
- Nasdaq Hearings Panel will consider the matter at hearing scheduled for December 16, 2024.
- Company intends to file delinquent reports as soon as practicable; no immediate effect on trading.

## SEC filing metadata
- accession: 0001493152-24-047421
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315224047421/0001493152-24-047421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315224047421/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047421
- JSON: https://secwatch.observer/filing/0001493152-24-047421.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047421.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.